Richard Marsden

About
Latest Posts

Richard Marsden is the CEO of Synairgen plc, a respiratory drug development company founded by the University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic

Latest posts by Richard Marsden (see all)

SNG001 Anti-Viral - 5th March 2016

The Hippocratic Post - silencer molecules

SNG001 Anti-Viral

Australasia, Cancer, Men's Health, Women's Health
Twins in breast cancer study
A burden shared is a burden halved: twins in breast cancer study: Melbourne identical twins Raie Moss and Judy Kohn are sharing their breast cancer journey to encourage other twins …
Cancer, Men's Health
Prostate cancer: immunotherapy offers hope
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the finding of the long-term analyses of an international phase 3 …
Heart & Lung, Heart Disease
Shouvik Haldar announced as new A-A HRC …
Dr Shouvik Haldar has been announced as the new A-A Heart Rhythm Congress Programme Director, following the decision by Dr Kim Rajappan to step down following a successful four-year tenure. …
Coronavirus, COVID-19 Update, Global Reach, Infection/Disease
Rapid $5 tests for low & middle …
WHO: Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries A full access package includes WHO policy guidance on the use of …
Cardiology, Heart & Lung, Heart Disease, Innovation
AI tech advances for World Heart Day
World Heart Day is the 29th September. Created by the World Heart Federation, World Heart Day informs people around the globe that CVD, including heart disease and stroke, is the …

The Royal Society of Medicine blogs

View all posts from The RSM »

LATEST: RSM - Poetry and politics: Paediatrics 2.0.